|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Stocks are rallying on tax bill optimism. But some analysts are warning that this will be a sell-the-news event — that tax cuts are already priced in, and that if the bill does become law, there will be a selloff. Yahoo Finance's Alexis Christoforous and Jared Blikre discuss.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Live Ventures, Inc. Here are 5 ETFs with the largest exposure to LIVE-US. Comparing the performance and risk of Live Ventures, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Grupo Financiero Galicia SA reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Grupo Financiero Galicia SA – Banco Macro SA Sponsored ADR Class B, BBVA Banco Frances SA Sponsored ADR, Banco Bradesco S.A. Sponsored ADR Pfd, Shinhan Financial Group ... Read more (Read more...)
Francesca's (FRAN) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
After months of turning up the heat on Deckers Outdoor Corp, hedge fund Marcato Capital Management recently proposed a settlement that the UGG boot maker rejected, a filing released on Monday shows. "Unfortunately Deckers swiftly rejected Marcato's settlement proposal and made clear through its counsel that Deckers was not interested in pursuing any settlement discussions with Marcato," Marcato Managing Partner Mick McGuire wrote to Deckers Chairman John Gibbons. In the letter McGuire said that part of his offer to settle included putting three Marcato nominees on the board.
Marcato said on Monday it was open to a proposal by Deckers Outdoor Corp's board to interview the activist investor's nominees only if the footwear maker was willing to reach a settlement agreement ahead of a shareholder meeting this week. Tensions have mounted between the two sides for months and may be resolved only at Deckers' upcoming annual meeting, on Dec. 14, when shareholders vote on board nominees. Marcato, which has an 8.5 percent stake in the footwear maker, has nominated three members, down from its earlier proposal to replace the company's entire nine-member board.
Marcato said Deckers Outdoor Corp's board agreed to interview its nominees ahead of the annual shareholder meeting this week, a move it called a record-building exercise and to gain advantage in a contentious ...
Shares of Banc of California Inc (NYSE:BANC) will begin trading ex-dividend in 3 days. To qualify for the dividend check of $0.13 per share, investors must have owned the sharesRead More...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Celldex Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CLDX-US. Comparing the performance and risk of Celldex Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Goods sector is rising.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Deckers Outdoor Corp. Here are 5 ETFs with the largest exposure to DECK-US. Comparing the performance and risk of Deckers Outdoor Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Dry shipping stocks TOP SHIPS Inc (NASDAQ: TOPS ), Euroseas Ltd. ( NASDAQ: ESEA) and DryShips Inc. (NASDAQ: DRYS ) are all trading higher Thursday as the Baltic Dry Shipping Index hits its highest level ...
The influential advisory firm now said it is recommending that shareholders support three dissident director candidates nominated by the activist.
Proxy advisory firm Institutional Shareholder Services on Wednesday suggested shareholders back hedge fund Marcato's choice of directors at Deckers Outdoor Corp , switching its recommendation after the U.S. fund made changes. In one of the season's most hotly contested proxy contests, activist investor Marcato Capital Management has proposed its own slate of directors to influence strategy at the maker of UGG boots. On Wednesday, ISS, a proxy advisory firm that issues voting recommendations for shareholders, wholly threw its weight behind Marcato, saying that the Deckers board has been too slow in addressing problems at the company and that it was time for a shake-up.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Grupo Financiero Galicia SA Here are 5 ETFs with the largest exposure to GGAL-US. Comparing the performance and risk of Grupo Financiero Galicia SA with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
A Relative Strength Rating upgrade for Deckers Outdoor shows improving technical performance.
A U.S. hedge fund that wants to make changes to the board of UGG boot maker Deckers Outdoor Corp reduced its demand on Monday from changing all nine directors to just three, likely improving its chance of victory. With ten days to go before shareholders cast votes in one of the season's most bitter proxy contests, activist investor Marcato Capital Management took an unusual step by essentially mounting a new contest with a smaller slate of directors. The San Francisco-based hedge fund, which owns 8.5 percent of Deckers, said in a regulatory filing that it was proposing three directors - after having spent months campaigning to replace all nine members of the board.
Celldex (CLDX) commences a phase I study on CDX-1140 for patients with advanced solid tumors. The study is designed to evaluate the safety and tolerability of the candidate at different dose levels.